Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents

Gynecological Endocrinology

Volumn 31, Issue 8, 2015, Pages 625-629

  Villarroel, Claudio ^a   López, Patricia ^a,b   Merino, Paulina M ^a   Iñiguez, Germán ^a   Sir Petermann, Teresa ^a   Codner, Ethel ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

Adolescence; androgens; biochemical hyperandrogenism; polycystic ovarian morphology; polycystic ovary syndrome

Indexed keywords

ANDROGEN; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; COMPLICATION; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADOLESCENT; FEMALE; HIRSUTISM; HUMANS; OLIGOMENORRHEA; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 84942779651     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1025380     Document Type: Article

References (30)

1. Villarroel C, Merino PM, Lopez P, et al. Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Hum Reprod 2011; 26: 2861-8
2. Sir-Petermann T, Codner E, Perez V, et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009; 94: 1923-30
3. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013; 98: 4565-92
4. American Academy of Pediatrics Committee on A, American College of O, Gynecologists Committee on Adolescent Health C., et al. Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006; 118: 2245-50
5. Tellez R, Frenkel J. Clinical evaluation of body hair in healthy women. Rev Med Chil 1995; 123: 1349-54
6. Codner E, Iniguez G, Villarroel, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007; 92: 4742-6
7. Codner E, Iniguez G, Hernandez IM, et al. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 2011; 74: 73-8
8. Codner E, Mook-Kanamori D, Bazaes RA, et al. Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 2005. 90: 3939-45
9. Codner E, Iniguez G, Villarroel C, et al. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. J Clin Endocrinol Metab 2007; 92: 4742-6
10. Codner E, Villarroel C, Eyzaguirre FC, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril 2011; 95: 702-6
11. Villarroel C, Trejo L, Munoz A, et al. Assessment of diagnostic competence of plasmatic androgens on polycystic ovary syndrome based on receiver operator characteristic curves. Gynecol Endocrinol 2010; 26: 600-6
12. Rotterdam ESHRE-ASRM-Sponosored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
13. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-43
14. Carmina E, Rosato F, Janni A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006; 91: 2-6
15. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-62
16. Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010; 93: 1938-41
17. Spencer JB, Klein M, Kumar A, et al. The age-associated decline of androgens in reproductive age and menopausal Black and White women. J Clin Endocrinol Metab 2007; 92: 4730-3
18. Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007; 92: 405-13
19. Silfen ME, Denburg MR, Manibo AM, et al. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003; 88: 4682-8
20. Gambineri A, Fanelli F, Prontera O, et al. Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students. J Clin Endocrinol Metab 2013; 98: 1641-50
21. Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol 2010; 203: 201 e1-5
22. Rieder J, Santoro N, Cohen HW, et al. Body shape and size and insulin resistance as early clinical predictors of hyperandrogenic anovulation in ethnic minority adolescent girls. J Adolesc Health 2008; 43: 115-24
23. Fruzzetti F, Perini D, Lazzarini V, et al. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril 2009; 92: 626-34
24. Bentzen JG, Forman JL, Johannsen TH, et al. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging. J Clin Endocrinol Metab 2013; 98: 1602-11
25. Barber TM, Alvey C, Greenslade T, et al. Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging. Eur Radiol 2010; 20: 1207-13
26. Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88: 5957-62
27. Rosenfield RL, Wroblewski K, Padmanabhan V, et al. Antimullerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries. Fertil Steril 2012; 98: 242-9
28. Hart R, Doherty DA, Norman RJ, et al. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril 2010; 94: 1118-21
29. Pawelczak M, Kenigsberg L, Milla S, et al. Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features. J Pediatr Endocrinol Metab 2012; 25: 983-9
30. Chu MC, Carmina E, Wang J, et al. Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B. Fertil Steril 2005; 84: 1685-8